Skip to Main Content

Paper Details

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.
J Med Chem
25
2021
Author NameAffiliation
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Tero AittokallioInstitute for Cancer Research, Oslo University Hospital
Tero AittokallioUniversity of Oslo
Richard MorigglInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
  • 1 - 4

Datasets

Release 1.2